The deoxyribonucleic acid (DNA) damage response (DDR) is a major feature in the maintenance of genome integrity and in the suppression of tumorigenesis. PALB2 (Partner and Localizer of Breast Cancer 2 (BRCA2)) plays an important role in maintaining genome integrity through its role in the Fanconi anemia (FA) and homologous recombination (HR) DNA repair pathways. Since its identification as a BRCA2 interacting partner, PALB2 has emerged as a pivotal tumor suppressor protein associated to hereditary cancer susceptibility to breast and pancreatic cancers. In this review, we discuss how other DDR proteins (such as the kinases Ataxia Telangiectasia Mutated (ATM) and ATM- and Rad3-Related (ATR), mediators BRCA1 (Breast Cancer 1)/BRCA2 and effecto...
PALB2 (Partner and Localizer of BRCA2) was first identified as a BRCA2-interacting protein. Subseque...
SummaryBRCA1 and BRCA2 are often mutated in familial breast and ovarian cancer. Both tumor suppresso...
Besides mutations in BRCA1/BRCA2, heterozygous defects in PALB2 are important in breast cancer predi...
SummaryBRCA1 and BRCA2 are often mutated in familial breast and ovarian cancer. Both tumor suppresso...
Homologous recombination (HR) is the only error-free pathway for the repair of DNA double strand bre...
Mutations in breast cancer susceptibility gene 1 and 2 {BRCA1 and BRCA2) predispose individuals to b...
Background: Germline mutations in the PALB2 gene are associated with the genetic disorder Fanconi an...
Homologous recombination mediated by the RAD51 recombinase helps eliminate chromosomal lesions, such...
DDR is often considered as a critical barrier during tumor initiation with most pre-malignant cells ...
Maintenance of genomic stability ensures faithful transmission of genetic information and helps supp...
Homologous recombination mediated by RAD51 recombinase helps eliminate chromosomal lesions, such as ...
Homologous recombination mediated by RAD51 recombinase helps eliminate chromosomal lesions, such as ...
Breast cancer is the most common cancer among women in the Czech Republic. Mutations in two major pr...
Homologous recombination mediated by RAD51 recombinase helps eliminate chromosomal lesions, such as ...
Background: Germline mutations in the PALB2 gene are associated with the genetic disorder Fanconi an...
PALB2 (Partner and Localizer of BRCA2) was first identified as a BRCA2-interacting protein. Subseque...
SummaryBRCA1 and BRCA2 are often mutated in familial breast and ovarian cancer. Both tumor suppresso...
Besides mutations in BRCA1/BRCA2, heterozygous defects in PALB2 are important in breast cancer predi...
SummaryBRCA1 and BRCA2 are often mutated in familial breast and ovarian cancer. Both tumor suppresso...
Homologous recombination (HR) is the only error-free pathway for the repair of DNA double strand bre...
Mutations in breast cancer susceptibility gene 1 and 2 {BRCA1 and BRCA2) predispose individuals to b...
Background: Germline mutations in the PALB2 gene are associated with the genetic disorder Fanconi an...
Homologous recombination mediated by the RAD51 recombinase helps eliminate chromosomal lesions, such...
DDR is often considered as a critical barrier during tumor initiation with most pre-malignant cells ...
Maintenance of genomic stability ensures faithful transmission of genetic information and helps supp...
Homologous recombination mediated by RAD51 recombinase helps eliminate chromosomal lesions, such as ...
Homologous recombination mediated by RAD51 recombinase helps eliminate chromosomal lesions, such as ...
Breast cancer is the most common cancer among women in the Czech Republic. Mutations in two major pr...
Homologous recombination mediated by RAD51 recombinase helps eliminate chromosomal lesions, such as ...
Background: Germline mutations in the PALB2 gene are associated with the genetic disorder Fanconi an...
PALB2 (Partner and Localizer of BRCA2) was first identified as a BRCA2-interacting protein. Subseque...
SummaryBRCA1 and BRCA2 are often mutated in familial breast and ovarian cancer. Both tumor suppresso...
Besides mutations in BRCA1/BRCA2, heterozygous defects in PALB2 are important in breast cancer predi...